Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples

被引：25

作者：

Latsuzbaia, Ardashel ^{[1
]}

Tapp, Jessica ^{[1
]}

Trung Nguyen ^{[1
]}

Fischer, Marc ^{[2
]}

Arbyn, Marc ^{[3
]}

Weyers, Steven ^{[4
]}

Mossong, Joel ^{[1
]}

机构：

[1] Lab Natl Sante, Surveillance & Epidemiol Infect Dis, Dudelange, Luxembourg

[2] Dept Med, Lab Natl Sante, Dudelange, Luxembourg

[3] Sci Inst Publ Hlth, Belgian Canc Ctr, Unit Canc Epidemiol, Brussels, Belgium

[4] Ghent Univ Hosp, Dept Obstet & Gynecol, Ghent, Belgium

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2016年 / 85卷 / 03期

关键词：

Anyplex II HPV28; Euroarray HPV; Human papilloma virus; HPV genotyping; Method comparison; Vaccine monitoring; HUMAN-PAPILLOMAVIRUS; CANCER; INFECTION; WOMEN; ASSAY; RISK;

D O I：

10.1016/j.diagmicrobio.2016.04.011

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Analytically accurate human papillomavirus (HPV) genotyping methods are required to assess the impact of HPV vaccination. The aim of this study was to evaluate the analytical performance of Anyplex II HPV28 (Seegene, Korea) and Euroarray HPV (Euroimmun, Germany) genotyping kits, for conducting a future HPV vaccine efficacy monitoring study in Luxembourg. A total number of 150 cervical swabs were collected from women with mean age 31.4 years. Agreements for detecting any HPV between Aptima/Anyplex (88.0%) and Aptima/Euroarray (90.7%) were similar. Agreement of Anyplex/EuroArray with Aptima was higher for Genotypes 16, 18 or 45 than for the other 11 HPVs. The average number of HPV genotypes detected per sample was similar with 2.6 and 2.5, for Anyplex and EuroArray, respectively. In conclusion, Anyplex and Euroarray showed high agreement in general and in particular for detecting genotypes contained in HPV vaccines. (C) 2016 Elsevier Inc. All rights reserved.

引用

页码：318 / 322

页数：5

共 30 条

[11] Recent trends in type-specific HPV infection rates in the United States [J].

Dickson, E. L. ;

Vogel, R. I. ;

Luo, X. ;

Downs, L. S. .

EPIDEMIOLOGY AND INFECTION, 2015, 143 (05) :1042-1047

[12] Cervical cytology and multiple type HPV infection: A study of 8182 women ages 31-65 [J].

Dickson, Elizabeth L. ;

Vogel, Rachel Isaksson ;

Geller, Melissa A. ;

Downs, Levi S., Jr. .

GYNECOLOGIC ONCOLOGY, 2014, 133 (03) :405-408

[13] Global Improvement in Genotyping of Human Papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study [J].

Eklund, Carina ;

Forslund, Ola ;

Wallin, Keng-Ling ;

Dillner, Joakim .

JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (02) :449-459

[14] Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV Assay for Human Papillomavirus Genotyping [J].

Estrade, C. ;

Sahli, R. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (02) :607-612

[15] Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 [J].

Ferlay, J. ;

Steliarova-Foucher, E. ;

Lortet-Tieulent, J. ;

Rosso, S. ;

Coebergh, J. W. W. ;

Comber, H. ;

Forman, D. ;

Bray, F. .

EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) :1374-1403

[16] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].

Ferlay, Jacques ;

Soerjomataram, Isabelle ;

Dikshit, Rajesh ;

Eser, Sultan ;

Mathers, Colin ;

Rebelo, Marise ;

Parkin, Donald Maxwell ;

Forman, David ;

Bray, Freddie .

INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386

[17] Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer [J].

Guan, Peng ;

Howell-Jones, Rebecca ;

Li, Ni ;

Bruni, Laia ;

de Sanjose, Silvia ;

Franceschi, Silvia ;

Clifford, Gary M. .

INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (10) :2349-2359

[18] Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer [J].

Halec, Gordana ;

Alemany, Laia ;

Lloveras, Belen ;

Schmitt, Markus ;

Alejo, Maria ;

Bosch, Franz X. ;

Tous, Sara ;

Ellen Klaustermeier, Jo ;

Guimera, Nuria ;

Grabe, Niels ;

Lahrmann, Bernd ;

Gissmann, Lutz ;

Quint, Wim ;

Bosch, Francesc X. ;

de Sanjose, Silvia ;

Pawlita, Michael .

JOURNAL OF PATHOLOGY, 2014, 234 (04) :441-451

[19] Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening [J].

Hesselink, A. T. ;

Sahli, R. ;

Berkhof, J. ;

Snijders, P. J. F. ;

van der Salm, M. L. ;

Agard, D. ;

Bleeker, M. C. G. ;

Heideman, D. A. M. .

JOURNAL OF CLINICAL VIROLOGY, 2016, 76 :36-39

[20]

International Agency for Research on Cancer (IARC), 2012, Biological agents, V100B

← 1 2 3 →